Back to OPRX
MARSHALL WACE, LLP OPRX Position History
OptimizeRx Corporation • Healthcare
Quarters held
22
Latest value
$3.4M
Q3 2026
Peak value
$3.4M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $1.3M |
| Q2 2023 | $1.6M |
| Q3 2023 | $289K |
| Q2 2024 | $457K |
| Q4 2024 | $103K |
| Q4 2024 | $551K |
| Q1 2025 | $212K |
| Q1 2025 | $2M |
| Q2 2025 | $51K |
| Q2 2025 | $1.5M |
| Q3 2025 | $2K |
| Q3 2025 | $718K |
| Q3 2025 | $2K |
| Q3 2025 | $4K |
| Q4 2025 | $129K |
| Q4 2025 | $114K |
| Q1 2026 | $41K |
| Q1 2026 | $156K |
| Q2 2026 | $16K |
| Q2 2026 | $912K |
| Q3 2026 | $401K |
| Q3 2026 | $3.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.4M | 411.3K | — | — |
| Q3 2026 | $401K | 48.1K | — | — |
| Q2 2026 | $912K | 159.4K | — | — |
| Q2 2026 | $16K | 2.7K | — | — |
| Q1 2026 | $156K | 24.8K | — | — |
| Q1 2026 | $41K | 6.5K | — | — |
| Q4 2025 | $114K | 9.3K | — | — |
| Q4 2025 | $129K | 10.5K | — | — |
| Q3 2025 | $4K | 200 | — | — |
| Q3 2025 | $2K | 100 | — | — |
| Q3 2025 | $718K | 35.0K | — | — |
| Q3 2025 | $2K | 95 | — | — |
| Q2 2025 | $1.5M | 108.2K | — | — |
| Q2 2025 | $51K | 3.7K | — | — |
| Q1 2025 | $2M | 226.6K | — | — |
| Q1 2025 | $212K | 24.5K | — | — |
| Q4 2024 | $551K | 113.3K | — | — |
| Q4 2024 | $103K | 21.1K | — | — |
| Q2 2024 | $457K | 45.7K | — | — |
| Q3 2023 | $289K | 37.1K | — | — |
| Q2 2023 | $1.6M | 112.1K | — | — |
| Q1 2023 | $1.3M | 87.3K | — | — |
Other funds holding OPRX
$19.3M
$13.9M
$12.4M
$12.1M
$12.1M